Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia

Summary

The purpose of this study is to determine the safety and efficacy of TAK-085, once daily (QD) or twice daily (BID), compared to ethyl eicosapentaenoate (EPA-E), three times daily (TID) in participants with hypertriglyceridemia undergoing lifestyle modification.

Timeline

Start

2009-11

Primary completion

2011-01

Completion

2011-01

Drugs

Indications